This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC London

Legal Notice

CLINICAL PHARMACY CONGRESS IS SPONSORED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. PHARMACEUTICAL COMPANIES HAVE SOLELY PROVIDED SPONSORSHIP THROUGH THE PURCHASE OF EXHIBITION SPACE AND/OR SPONSORED SPEAKER SESSIONS WITH NO FURTHER INPUT INTO THE ARRANGEMENTS OR AGENDA OF THE MEETING. SESSIONS DELIVERED WITH INPUT FROM OUR SPONSORS WILL ALWAYS BE MARKED ON THE PROGRAMME. A FULL LIST OF CONFIRMED SPONSORS FOR CLINICAL PHARMACY CONGRESS LONDON IS AVAILABLE HERE.  

CPC 2026 Content Programme

Subpage Hero

.

Loading

From evidence to action: optimising metabolic dysfunction-associated steatotic liver disease (MASLD) management in pharmacy practice

08 May 2026
Technical Services Theatre
From evidence to action: optimising metabolic dysfunction-associated steatotic liver disease (MASLD) management in pharmacy practice
Approximately 1 in 5 patients in the UK are currently living with metabolic-dysfunction associated liver disease (MASLD). This presentation will equip pharmacy professionals with the knowledge to identify and manage MASLD in primary and secondary care.
Speakers
Leslie Wong, Advanced Clinical Pharmacist – Hepatology and the Eastern Liver Network - British Hepatology Pharmacy Group
Aimee Francisco, Advanced Specialist Pharmacist – Gastroenterology - Gloucestershire Hospitals NHS Foundation Trust

Newsletter Sign Up